Logo of straninfSexually Transmitted InfectionsVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Sex Transm Infect. Feb 2005; 81(1): 53–58.
PMCID: PMC1763716

Screening injecting drug users for sexually transmitted infections and blood borne viruses using street outreach and self collected sampling


Background: Injecting drug users (IDUs) are a marginalised population, who infrequently access health services for screening for sexually transmitted infections (STIs) and blood borne viruses (BBVs), and are at high risk of these infections.

Objectives: To use street outreach and self collection of samples for STI screening, to establish the prevalence of BBVs and STIs, and to identify risk behaviours among a group of culturally diverse street based IDUs.

Methods: This was a cross sectional study of 314 IDUs in the central business district of Melbourne, Australia, conducted over 3 years (1999–2002). We used street outreach as the recruitment strategy with staff "on foot" in injecting and dealing locations, as well as self collected genital sampling to increase acceptance of screening for Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis by polymerase chain reaction (PCR). Individuals were screened for hepatitis A, B, and C, syphilis and HIV, and given the option of a self collected or clinician collected blood sample to increase acceptance of screening for BBVs.

Results: Street outreach was highly effective and self directed STI sampling was more acceptable than practitioner directed sampling (76% versus 9% acceptance, p<0.001). There was a high prevalence of hepatitis C (74%, 95% CI 69 to 79), STIs (8% (5 to 13)), and chlamydia (6% (3 to 10)), and past exposure to hepatitis A and B was common. High rates of recent sharing of injecting equipment, unprotected sex and casual sexual partners, together with low levels of awareness of current hepatitis C infection were identified.

Conclusion: Street outreach and self collected genital samples facilitate screening for STIs and BBVs in IDUs and revealed a high prevalence of infections and risk behaviours.

Full Text

The Full Text of this article is available as a PDF (94K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Ross MW, Gold J, Wodak A, Miller ME. Sexually transmissible diseases in injecting drug users. Genitourin Med. 1991 Feb;67(1):32–36. [PMC free article] [PubMed]
  • Ross Michael W, Hwang Lu-Yu, Zack Carolyn, Bull Lara, Williams Mark L. Sexual risk behaviours and STIs in drug abuse treatment populations whose drug of choice is crack cocaine. Int J STD AIDS. 2002 Nov;13(11):769–774. [PubMed]
  • Poulin C, Alary M, Bernier F, Carbonneau D, Boily MC, Joly JR. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae among at-risk women, young sex workers, and street youth attending community organizations in Quebec City, Canada. Sex Transm Dis. 2001 Aug;28(8):437–443. [PubMed]
  • van den Hoek A. STD control in drug users and street youth. Genitourin Med. 1997 Aug;73(4):240–244. [PMC free article] [PubMed]
  • Miller Maureen, Mella Inge, Moi Harald, Eskild Anne. HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway. J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):373–379. [PubMed]
  • MacDonald MA, Wodak AD, Dolan KA, van Beek I, Cunningham PH, Kaldor JM. Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997. Collaboration of Australian NSPs. Med J Aust. 2000 Jan 17;172(2):57–61. [PubMed]
  • van Beek I, Buckley R, Stewart M, MacDonald M, Kaldor J. Risk factors for hepatitis C virus infection among injecting drug users in Sydney. Genitourin Med. 1994 Oct;70(5):321–324. [PMC free article] [PubMed]
  • Freeman AJ, Zekry A, Whybin LR, Harvey CE, van Beek IA, de Kantzow SL, Rawlinson WD, Boughton CR, Robertson PW, Marinos G, et al. Hepatitis C prevalence among Australian injecting drug users in the 1970s and profiles of virus genotypes in the 1970s and 1990s. Med J Aust. 2000 Jun 19;172(12):588–591. [PubMed]
  • Des Jarlais Don C, Diaz Theresa, Perlis Theresa, Vlahov David, Maslow Carey, Latka Mary, Rockwell Russell, Edwards Vincent, Friedman Samuel R, Monterroso Edgar, et al. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol. 2003 Mar 1;157(5):467–471. [PubMed]
  • Crofts N, Hopper JL, Bowden DS, Breschkin AM, Milner R, Locarnini SA. Hepatitis C virus infection among a cohort of Victorian injecting drug users. Med J Aust. 1993 Aug 16;159(4):237–241. [PubMed]
  • Law Matthew G, Batey Robert G. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase. Med J Aust. 2003 Mar 3;178(5):197–198. [PubMed]
  • Crofts N, Aitken CK. Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995. Med J Aust. 1997 Jul 7;167(1):17–20. [PubMed]
  • Crofts N, Cooper G, Stewart T, Kiely P, Coghlan P, Hearne P, Hocking J. Exposure to hepatitis A virus among blood donors, injecting drug users and prison entrants in Victoria. J Viral Hepat. 1997 Sep;4(5):333–338. [PubMed]
  • Rhodes Tim, Lowndes Catherine, Judd Ali, Mikhailova Larissa A, Sarang Anya, Rylkov Andrey, Tichonov Mikhail, Lewis Kim, Ulyanova Nina, Alpatova Tatiana, et al. Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS. 2002 Sep 6;16(13):F25–F31. [PubMed]
  • Shafer Kimberly Page, Hahn Judith A, Lum Paula J, Ochoa Kristen, Graves Alison, Moss Andrew. Prevalence and correlates of HIV infection among young injection drug users in San Francisco. J Acquir Immune Defic Syndr. 2002 Dec 1;31(4):422–431. [PubMed]
  • van Beek I, Dwyer R, Dore GJ, Luo K, Kaldor JM. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ. 1998 Aug 15;317(7156):433–437. [PMC free article] [PubMed]
  • Tabrizi SN, Paterson B, Fairley CK, Bowden FJ, Garland SM. A self-administered technique for the detection of sexually transmitted diseases in remote communities. J Infect Dis. 1997 Jul;176(1):289–292. [PubMed]
  • Tabrizi SN, Chen S, Borg AJ, Lees MI, Fairley CK, Jackson HD, Gust CH, Migliorini G, Garland SM. Patient-administered tampon-collected genital cells in the assessment of Chlamydia trachomatis infection using polymerase chain reaction. Sex Transm Dis. 1996 Nov-Dec;23(6):494–497. [PubMed]
  • Miller Cari L, Tyndall Mark, Spittal Patricia, Li Kathy, Palepu Anita, Schechter Martin T. Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges. J Urban Health. 2002 Jun;79(2):257–265. [PMC free article] [PubMed]
  • Knox Janet, Tabrizi Sepehr N, Miller Penny, Petoumenos Kathy, Law Mathew, Chen Shujun, Garland Suzanne M. Evaluation of self-collected samples in contrast to practitioner-collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas. Sex Transm Dis. 2002 Nov;29(11):647–654. [PubMed]
  • Paterson BA, Tabrizi SN, Garland SM, Fairley CK, Bowden FJ. The tampon test for trichomoniasis: a comparison between conventional methods and a polymerase chain reaction for Trichomonas vaginalis in women. Sex Transm Infect. 1998 Apr;74(2):136–139. [PMC free article] [PubMed]
  • Resnick RM, Cornelissen MT, Wright DK, Eichinger GH, Fox HS, ter Schegget J, Manos MM. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst. 1990 Sep 19;82(18):1477–1484. [PubMed]
  • Tabrizi SN, Chen S, Cohenford MA, Lentrichia BB, Coffman E, Shultz T, Tapsall JW, Garland SM. Evaluation of real time polymerase chain reaction assays for confirmation of Neisseria gonorrhoeae in clinical samples tested positive in the Roche Cobas Amplicor assay. Sex Transm Infect. 2004 Feb;80(1):68–71. [PMC free article] [PubMed]
  • Tabrizi SN, Paterson BA, Fairley CK, Bowden FJ, Garland SM. Comparison of tampon and urine as self-administered methods of specimen collection in the detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in women. Int J STD AIDS. 1998 Jun;9(6):347–349. [PubMed]
  • Rosenthal DA, Fairley CK, Garland SM, Tabrizi SN, Raynor K, Edwards C, Gregson S, Walsh J. Homeless young people: an important risk group for sexually transmitted infections. Med J Aust. 2000 Mar 6;172(5):244–244. [PubMed]
  • Williams H, Tabrizi SN, Lee W, Kovacs GT, Garland S. Adolescence and other risk factors for Chlamydia trachomatis genitourinary infection in women in Melbourne, Australia. Sex Transm Infect. 2003 Feb;79(1):31–34. [PMC free article] [PubMed]
  • François Guido, Hallauer Johannes, Van Damme Pierre. Hepatitis B vaccination: how to reach risk groups. Vaccine. 2002 Nov 22;21(1-2):1–4. [PubMed]
  • Hocking Jane S, Higgs Peter G, Keenan Cathy M, Crofts Nick. HIV among injecting drug users of Indo-Chinese ethnicity in Victoria. Med J Aust. 2002 Feb 18;176(4):191–192. [PubMed]
  • Maher L, Sargent P, Higgs P, Crofts N, Kelsall J, Le TT. Risk behaviours of young Indo-Chinese injecting drug users in Sydney and Melbourne. Aust N Z J Public Health. 2001;25(1):50–54. [PubMed]
  • Reid G, Crofts N, Beyer L. Drug treatment services for ethnic communities in Victoria, Australia: an examination of cultural and institutional barriers. Ethn Health. 2001 Feb;6(1):13–26. [PubMed]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...